Seyfarth J - Search Results

1

Mannose-binding lectin and its genetic variants.

Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Garred P, et al. Among authors: seyfarth j. Genes Immun. 2006 Mar;7(2):85-94. doi: 10.1038/sj.gene.6364283. Genes Immun. 2006. PMID: 16395391 Review.

2

Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes.

Seyfarth J, Garred P, Madsen HO. Seyfarth J, et al. Mol Immunol. 2006 Mar;43(7):962-71. doi: 10.1016/j.molimm.2005.06.033. Epub 2005 Aug 19. Mol Immunol. 2006. PMID: 16112196

3

The 'involution' of mannose-binding lectin.

Seyfarth J, Garred P, Madsen HO. Seyfarth J, et al. Hum Mol Genet. 2005 Oct 1;14(19):2859-69. doi: 10.1093/hmg/ddi318. Epub 2005 Aug 22. Hum Mol Genet. 2005. PMID: 16115813

4

Post-induction residual disease in translocation t(12;21)-positive childhood ALL.

Seyfarth J, Madsen HO, Nyvold C, Ryder LP, Clausen N, Jonmundsson GK, Wesenberg F, Schmiegelow K. Seyfarth J, et al. Med Pediatr Oncol. 2003 Feb;40(2):82-7. doi: 10.1002/mpo.10217. Med Pediatr Oncol. 2003. PMID: 12461790

5

Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance.

Schmiegelow K, Nyvold C, Seyfarth J, Pieters R, Rottier MM, Knabe N, Ryder LP, Madsen HO, Svejgaard A, Kaspers GJ. Schmiegelow K, et al. Among authors: seyfarth j. Leukemia. 2001 Jul;15(7):1066-71. doi: 10.1038/sj.leu.2402144. Leukemia. 2001. PMID: 11455975

6

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome.

Nyvold C, Madsen HO, Ryder LP, Seyfarth J, Svejgaard A, Clausen N, Wesenberg F, Jonsson OG, Forestier E, Schmiegelow K; Nordic Society for Pediatric Hematology and Oncology. Nyvold C, et al. Among authors: seyfarth j. Blood. 2002 Feb 15;99(4):1253-8. doi: 10.1182/blood.v99.4.1253. Blood. 2002. PMID: 11830473

7

Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia.

Nyvold C, Madsen HO, Ryder LP, Seyfarth J, Engel CA, Svejgaard A, Wesenberg F, Schmiegelow K. Nyvold C, et al. Among authors: seyfarth j. J Immunol Methods. 2000 Jan 13;233(1-2):107-18. doi: 10.1016/s0022-1759(99)00113-1. J Immunol Methods. 2000. PMID: 10648861

8

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

Ramakers-van Woerden NL, Pieters R, Loonen AH, Hubeek I, van Drunen E, Beverloo HB, Slater RM, Harbott J, Seyfarth J, van Wering ER, Hählen K, Schmiegelow K, Janka-Schaub GE, Veerman AJ. Ramakers-van Woerden NL, et al. Among authors: seyfarth j. Blood. 2000 Aug 1;96(3):1094-9. Blood. 2000. PMID: 10910927

9

Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients.

Vivekanandan MM, Adankwah E, Aniagyei W, Acheampong I, Yeboah A, Arthur JF, Lamptey MNK, Abass MK, Gawusu A, Kumbel F, Osei-Yeboah F, Debrah LB, Owusu DO, Debrah A, Mayatepek E, Seyfarth J, Phillips RO, Jacobsen M. Vivekanandan MM, et al. Among authors: seyfarth j. Infection. 2022 Jun 27. doi: 10.1007/s15010-022-01870-3. Online ahead of print. Infection. 2022. PMID: 35759173

10

Myoinhibitory peptides in the central complex of the locust Schistocerca gregaria and colocalization with locustatachykinin-related peptides.

Hensgen R, Dippel S, Hümmert S, Jahn S, Seyfarth J, Homberg U. Hensgen R, et al. Among authors: seyfarth j. J Comp Neurol. 2022 Jun 14. doi: 10.1002/cne.25374. Online ahead of print. J Comp Neurol. 2022. PMID: 35700405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results